U.S. courtroom points non permanent restraining order on $27.8 billion Amgen-Horizon deal By Reuters

© Reuters. FILE PHOTO: An Amgen signal is seen on the firm’s workplace in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith

(Reuters) – A U.S. district courtroom has issued a brief restraining order on Amgen Inc (NASDAQ:)’s $27.8 billion acquisition of Horizon Therapeutics (NASDAQ:) following a submission for it by the 2 corporations and the U.S. Federal Commerce Fee, Amgen mentioned on Wednesday.

Below the order, Amgen and Horizon wouldn’t shut their transaction till the sooner of Sept. 15 or the second enterprise day after the courtroom guidelines on the FTC’s lawsuit filed on Tuesday.

Supply hyperlink

from NYSE Updates – My Blog https://ift.tt/RwKiomG
via IFTTT